How Insects Balance Reproductive Output and Immune Investment
Insects · 17.03.2025 · 16 (3) · 311
DOI: 10.3390/insects16030311 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Insects, online erschienen am 17.03.2025. Verfasst von Jimena Leyria und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba 5000, CP, Argentina. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Proyectos de Investigación Científica y Tecnológica (PICT) de FonCyT-ANPCyT, Proyectos de Investigación Bianuales para Investigadoras/es Asistentes y Adjuntas/os de reciente ingreso al CONICET (PIBBA), Subsidio a Proyectos de Investigación, Desarrollo Tecnológico y Artístico (PIDTA 2023), línea Consolidar, otorgado por la Secretaría de Ciencia y Tecnología (S….
Abstract (Originalsprache)
Insects face the constant challenge of balancing energy allocation between reproduction and immune responses, both of which are highly energy-demanding processes. Immune challenges frequently result in decreased fecundity, reduced egg viability, and delayed ovarian development. Conversely, heightened reproductive activity often suppresses immune functions. This trade-off has profound ecological and evolutionary consequences, shaping insects’ survival, adaptation, and population dynamics. The intricate interplay between reproduction and immunity in insects is regulated by the neuroendocrine and endocrine systems, which orchestrate resource distribution alongside other biological processes. Key hormones, such as juvenile hormone and ecdysteroids, serve as central regulators, influencing both immune responses and reproductive activities. Additionally, macromolecules like vitellogenin and lipophorin, primarily known for their functions as yolk protein precursors and lipid carriers, play crucial roles in pathogen recognition and transgenerational immune priming. Advancements in molecular and omics tools have unveiled the complexity of these regulatory mechanisms, providing new insights into how insects dynamically allocate resources to optimize their fitness. This delicate balance underscores critical evolutionary strategies and the integration of physiological systems across species. This review synthesizes insights from life history theory, oogenesis, and immunity, offering new perspectives on the trade-offs between reproductive output and immune investment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba 5000, CP, Argentina.
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba 5000, CP, Argentina.
ORCID-Profile: Jimena Leyria, Leonardo L Fruttero, Pedro A Paglione
Förderung
- Proyectos de Investigación Científica y Tecnológica (PICT) de FonCyT-ANPCyT
- Proyectos de Investigación Bianuales para Investigadoras/es Asistentes y Adjuntas/os de reciente ingreso al CONICET (PIBBA)
- Subsidio a Proyectos de Investigación, Desarrollo Tecnológico y Artístico (PIDTA 2023), línea Consolidar, otorgado por la Secretaría de Ciencia y Tecnología (S…
- CONICET
- FONCyT
- SECyT-UNC
Zitieren
APA
Leyria, J., Fruttero, L. L., Paglione, P. A., & Canavoso, L. E. (2025). How Insects Balance Reproductive Output and Immune Investment. Insects, 16(3), 311. https://doi.org/10.3390/insects16030311
Vancouver
Leyria J, Fruttero LL, Paglione PA, Canavoso LE. How Insects Balance Reproductive Output and Immune Investment. Insects. 2025;16(3):311. doi:10.3390/insects16030311
BibTeX
@article{Leyria2025,
author = {Leyria, Jimena and Fruttero, Leonardo L and Paglione, Pedro A and Canavoso, Lilián E},
title = {How Insects Balance Reproductive Output and Immune Investment},
journal = {Insects},
year = {2025},
volume = {16},
number = {3},
pages = {311},
doi = {10.3390/insects16030311}
}
EUVIMED